The start-up firm VB Devices has partnered with the Eurecat technology centre (a member of Tecnio) to develop a new automated device that eliminates varicose veins using sclerotherapy (the most common treatment option for this complaint). Sclerotherapy involves the application of a foam-based medication which acts on the affected vein, causing it to close and gradually disappear.
VB Devices aims to work with Eurecat to produce the device on an industrial scale and obtain regulatory permission to sell it during the second half of 2019. The goal is to launch the product, which will be marketed under the name Purespume, during the first quarter of 2020 through an international network of specialist distributors.
The innovation is based on a patent filed by the vascular surgeon Enric Roche, who came up with the idea after observing the need for such a device in his daily practice. He subsequently set up VB Devices in partnership with Federico Grego, who helped Roche develop the device and bring it to market.
“The new system consists of a capsule which uses an adapted magnetic agitator to produce foam of the required consistency and quality. The foam is produced automatically and homogeneously in just 30 seconds, meaning doctors will no longer have to produce it themselves using imprecise manual processes”, Dr Roche explained.